Case Reports in Medicine (Jan 2019)

Diffuse Alveolar Hemorrhage Caused by Warfarin after Rifampicin Discontinuation

  • Takashige Kiyota,
  • Seiji Shiota,
  • Ryosuke Hamanaka,
  • Daisuke Tsutsumi,
  • Takeshi Takakura,
  • Eishi Miyazaki

DOI
https://doi.org/10.1155/2019/4917856
Journal volume & issue
Vol. 2019

Abstract

Read online

An 83-year-old man under warfarin therapy presented for assessment of prolonged prothrombin time and cough. High-resolution computed tomography findings of the chest showed diffuse alveolar hemorrhage. His international normalized ratio (INR) was 11.89. He had been treated with rifampicin for a persistent infection, but this had been discontinued about two months before admission. Rifampicin suppresses the anticoagulant activity of warfarin, which can lead to a need for increased doses of warfarin to achieve and maintain a therapeutic INR. More frequent INR monitoring is needed even after discontinuing rifampicin.